---

---

entities : Abbott laboratories    symbols : SNY   

save search

---

AstraZeneca Wins Label Expansion for Severe Asthma Drug in Younger Kids
Published: 2024-04-12 (Crawled : 14:30) - biospace.com/
PRGO | $29.94 -0.33% 0.0% 970K |

Health Technology

| -3.96% | O: -0.13% H: 0.0% C: -2.94%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -3.93% | O: -1.65% H: 0.0% C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -3.16% | O: -1.06% H: 0.21% C: -1.05%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -2.73% | O: -3.02% H: 0.0% C: 0.0%
drug label astrazeneca expansion for kids

---

Consumer Healthcare Market, 33% of Growth to Originate from North America, Technavio
Published: 2024-04-10 (Crawled : 18:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -1.64% | O: -100.0% H: NaN% C: Infinity%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -4.55% | O: -0.64% H: 0.0% C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -2.91% | O: 0.43% H: 0.3% C: -0.18%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -2.68% | O: 0.05% H: 0.0% C: 0.0%
growth

---

Busy Weekend Sees Tumor-Agnostic Win for Enhertu, Another Rejection for Supernus
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| 0.01% | O: 2.24% H: 0.0% C: -0.8%
PRGO | $29.94 -0.33% 0.0% 970K |

Health Technology

| -4.33% | O: 0.96% H: 1.17% C: 0.16%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -5.09% | O: -0.48% H: 0.0% C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -2.94% | O: 0.09% H: 0.16% C: -0.7%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -1.74% | O: 0.84% H: 0.0% C: 0.0%
for

---

FDA Greenlights New Antibiotic for SAB, Pneumonia
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -3.54% | O: -1.77% H: 0.0% C: -1.81%
PRGO | $29.94 -0.33% 0.0% 970K |

Health Technology

| -4.48% | O: -0.22% H: 0.8% C: 0.06%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -6.83% | O: -1.84% H: 0.0% C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -1.98% | O: -0.37% H: 1.42% C: 1.37%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -5.11% | O: -3.44% H: 0.0% C: 0.0%
fda for

---

FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published: 2024-04-03 (Crawled : 13:30) - biospace.com/
PRGO | $29.94 -0.33% 0.0% 970K |

Health Technology

| -4.09% | O: -0.29% H: 1.34% C: -0.64%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -8.22% | O: 0.02% H: 0.0% C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -3.65% | O: 0.11% H: 0.37% C: -0.77%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -3.33% | O: 0.69% H: 0.0% C: 0.0%
fda drug schizophrenia

---

AstraZeneca Kicks Off April With New PNH Approval
Published: 2024-04-02 (Crawled : 13:30) - biospace.com/
PRGO | $29.94 -0.33% 0.0% 970K |

Health Technology

| -6.45% | O: -1.09% H: 0.13% C: -1.39%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -8.25% | O: -0.77% H: 0.8% C: 0.74%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -3.71% | O: -0.18% H: 0.47% C: 0.12%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -5.44% | O: -1.14% H: 0.02% C: -1.06%
approval astrazeneca

---

Global Infectious Enteritis Treatment Market Report 2024: A USD$937.7 Million Market by 2034 - Antibiotics Segment Dominates the Market
Published: 2024-03-29 (Crawled : 23:00) - prnewswire.com
ARDX | News | $6.445 -1.6% -1.63% 3.5M |

Health Technology

| Email alert Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| Email alert Add to watchlist
GLAXF | $20.2 -14.18% 510 |

Health Technology

| Email alert Add to watchlist
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| Email alert Add to watchlist
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| Email alert Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| Email alert Add to watchlist
report million treatment antibiotics global market

---

FDA Approves Treatments for Anemia in Chronic Kidney Disease, Hepatitis
Published: 2024-03-29 (Crawled : 19:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| Email alert Add to watchlist
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| Email alert Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| Email alert Add to watchlist
PRGO | $29.94 -0.33% 0.0% 970K |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| Email alert Add to watchlist
fda hepatitis kidney anemia

---

Pharmaceutical Market In Canada size is set to grow by USD 8.73 bn from 2024-2028, Abbott Laboratories, AbbVie Inc. & Amgen Inc., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-03-27 (Crawled : 22:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -4.72% | O: 0.99% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -7.02% | O: -1.17% H: 0.0% C: -0.89%
AZNCF | $140.15 -4.19% 560 |

Health Technology

| 0.45% | O: 0.89% H: 0.78% C: 0.78%
NVSEF | $93.6375 6.88% 82K |

Health Technology

| -2.13% | O: -100.0% H: NaN% C: Infinity%
NVS | $92.57 -0.55% 0.0% 910K |

Health Technology

| -2.92% | O: 0.52% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -7.89% | O: 0.02% H: 0.51% C: -0.3%
BMY | $48.3 0.96% -0.1% 11M |

Health Technology

| -9.37% | O: 0.26% H: 2.03% C: 1.57%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| -9.11% | O: 0.36% H: 0.72% C: 0.61%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -3.69% | O: 1.04% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -7.26% | O: -0.96% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M |

Health Technology

| 0.01% | O: -0.12% H: 0.25% C: -0.63%
AMGN | $262.77 -0.49% -0.49% 2M |

Health Technology

| -6.76% | O: 0.54% H: 0.0% C: 0.0%
abbvie set canada key market

---

FDA Approves New Treatments for Two Rare Diseases
Published: 2024-03-27 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -7.26% | O: -0.26% H: 0.0% C: 0.0%
PRGO | $29.94 -0.33% 0.0% 970K |

Health Technology

| -2.47% | O: 0.84% H: 1.48% C: 1.29%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -6.98% | O: 0.3% H: 0.0% C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -2.27% | O: 1.48% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -6.28% | O: 1.06% H: 0.0% C: 0.0%
fda rare

---

Regeneron Hit With Two CRLs, J&J’s PAH Treatment Approved
Published: 2024-03-25 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -1.09% | O: -100.0% H: NaN% C: Infinity%
PRGO | $29.94 -0.33% 0.0% 970K |

Health Technology

| -4.09% | O: 0.35% H: 0.35% C: -1.34%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -6.94% | O: 0.04% H: 0.0% C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -2.39% | O: -0.07% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -4.08% | O: 0.42% H: 0.0% C: 0.0%
approved treatment

---

Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nods for DMD, Hypertension
Published: 2024-03-22 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -2.65% | O: -1.58% H: 0.0% C: 0.0%
PRGO | $29.94 -0.33% 0.0% 970K |

Health Technology

| -4.88% | O: 0.35% H: 0.99% C: -1.17%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -6.92% | O: 0.02% H: 0.0% C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -3.63% | O: -0.43% H: 0.41% C: -0.85%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -2.84% | O: 1.47% H: 0.23% C: -0.19%
fda hypertension

---

Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nod for DMD, Hypertension
Published: 2024-03-22 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -2.65% | O: -1.58% H: 0.0% C: 0.0%
PRGO | $29.94 -0.33% 0.0% 970K |

Health Technology

| -4.88% | O: 0.35% H: 0.99% C: -1.17%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -6.92% | O: 0.02% H: 0.0% C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -3.63% | O: -0.43% H: 0.41% C: -0.85%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -2.84% | O: 1.47% H: 0.23% C: -0.19%
fda hypertension

---

Iron Drugs Market size to grow by USD 3.55 billion from 2022 to 2027, Technavio
Published: 2024-03-22 (Crawled : 03:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -3.81% | O: -1.71% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -2.65% | O: -1.58% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M |

Health Technology

| -6.54% | O: 0.4% H: 0.33% C: -0.45%
ABBV | News | $164.66 0.25% -0.15% 4.5M |

Health Technology

| -7.19% | O: 0.16% H: 0.0% C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -3.63% | O: -0.43% H: 0.41% C: -0.85%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -2.84% | O: 1.47% H: 0.23% C: -0.19%
market

---

FDA Approves Takeda’s Iclusig for Type of Leukemia, Idorsia’s Hypertension Drug
Published: 2024-03-21 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K |

Health Technology

| -2.29% | O: 0.14% H: 0.24% C: 0.24%
PRGO | $29.94 -0.33% 0.0% 970K |

Health Technology

| -4.03% | O: 0.0% H: 1.6% C: 0.89%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -6.95% | O: -0.03% H: 0.0% C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -4.17% | O: -0.56% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -2.56% | O: 0.3% H: 0.0% C: 0.0%
fda drug iclusig hypertension

---

FDA Approves First Gene Therapy for Rare Pediatric Disease
Published: 2024-03-18 (Crawled : 23:00) - biospace.com/
PRGO | $29.94 -0.33% 0.0% 970K |

Health Technology

| -1.09% | O: 0.33% H: 0.13% C: -1.51%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -8.52% | O: 0.2% H: 0.08% C: -1.14%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -4.83% | O: 1.71% H: 0.36% C: -2.52%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -4.77% | O: -0.81% H: 0.0% C: 0.0%
fda rare first disease therapy

---

Madrigal’s Rezdiffra, BMS’s Breyanzi Lead Week of Landmark FDA Approvals
Published: 2024-03-15 (Crawled : 15:00) - biospace.com/
PRGO | $29.94 -0.33% 0.0% 970K |

Health Technology

| -2.69% | O: -0.62% H: 0.59% C: -1.01%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -9.96% | O: -1.58% H: 0.0% C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -10.1% | O: -5.53% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -4.79% | O: -0.02% H: 0.0% C: 0.0%
fda breyanzi week

---

Pharmaceutical and Biotechnology Royalty Rates Report 2024: Essential Benchmark Data for Dealmakers - Royalty Rates, Deal Financials, Contract Documents, Royalty Rate Trends
Published: 2024-03-14 (Crawled : 00:00) - prnewswire.com
MS | News 0 d | $90.26 0.2% 0.0% 6.7M |

Finance

| 1.05% | O: -0.39% H: 0.45% C: 0.11%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -10.56% | O: -0.51% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -4.57% | O: 0.23% H: 0.0% C: 0.0%
NKTR | $1.3 -3.7% -3.85% 3.6M |

Health Technology

| 58.82% | O: 2.35% H: 2.3% C: -1.15%
IMAB | $1.795 -0.83% -0.84% 140K |

Health Technology

| -1.63% | O: -1.63% H: 0.55% C: -0.55%
report contract royalty trends deal

---

Global Antidiabetics Market 10 Year Forecast Report 2024-2034, by Product Type, by Application, by Distribution Channel and Region
Published: 2024-03-13 (Crawled : 18:00) - prnewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M |

Health Technology

| -7.83% | O: -0.64% H: 0.94% C: -0.56%
JNJ | News | $145.74 0.67% 0.0% 9.3M |

Health Technology

| -10.31% | O: 0.66% H: 0.0% C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M |

Health Technology

| -0.55% | O: 0.27% H: 0.5% C: 0.11%
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -10.19% | O: 0.41% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -4.61% | O: -0.04% H: 0.0% C: 0.0%
report distribution year global market

---

Global Fibrate Drugs Market Report 2024: A $5.14 Billion Market by 2034, Rising from S2.95 Billion in 2023
Published: 2024-03-11 (Crawled : 17:00) - prnewswire.com
ABT | News | $105.27 -0.6% -0.15% 7.3M |

Health Technology

| -10.65% | O: 0.26% H: 0.0% C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M |

Health Technology

| -4.06% | O: 0.57% H: 0.0% C: 0.0%
report global market

---

Gainers vs Losers

64%

36%

Top 10 Gainers

AGBA | News | $1.02 155.0% 57.94% 120M |

Finance

ZCMD | $2.86 108.76% 52.1% 2.3M |

Commercial Services

INVO | $1.555 104.6% 51.13% 5M |

Health Technology

ISPC | $0.437 105.16% 49.53% 37M |

Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M |

OST | $0.499 21.38% 45.26% 1.9M |

XPON | News | $3.1 60.62% 37.74% 17M |

TIRX | $0.7 44.39% 30.74% 58M |

BNTC | News | $6.92 44.17% 30.64% 3.5M |

Health Technology

GGE | $0.035 19.86% 29.3% 64M |

---

Your saved searches

---